TM00214: Lung Adenocarcinoma

The Jackson Laboratory

Contact Provider

View Data at JAX

 Download PDF
Related Models
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
NSG NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
Not Specified Not Specified Not Specified Not Specified 0, 2
NSG NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
not specified heterotopic pleural effusion Not Specified 1
Model Quality Control
Technique Description Passage
validation is pending. validation is pending. not specified
Patient
Sex female
Ethnicity not hispanic or latino
Derived Model TM00214
Patient Tumor Collection For PDX Model
Collection (Current Model)
Age not specified
Diagnosis Lung Adenocarcinoma
Type primary
PDX Mouse TM00214
Collection Site lung
Grade ( Classification: ajcc)
Stage ajcc iiib ( Classification: ajcc)
Sample ID Sample Type Engrafted Tumor Passage Data Type Data Available Platform Used Raw Data
LG1011PE1607P0000P1002P2 Engrafted Tumor Passage 2 expression View data stRNA Seq Not Available
LG1011PE1607P0000P1002P2 Engrafted Tumor Passage 2 mutation View data CTP Not Available
LG1011PE1607P0 Engrafted Tumor Passage 0 expression View data hu133 Not Available
LG1011PE1607P0 Engrafted Tumor Passage 0 mutation View data Truseq JAX Not Available

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform:    

Dosing study protocol
Drug Dose Response
Cisplatin 2.0mg/kg Progressive Disease
Docetaxel 10.0mg/kg Partial Response
Dextrose Monohydrate 5.0ml/kg Progressive Disease